...
首页> 外文期刊>The Egyptian Journal of Hospital Medicine >Serum Leptin in Patients with Chronic Renal Failure on Different Modes of Management
【24h】

Serum Leptin in Patients with Chronic Renal Failure on Different Modes of Management

机译:慢性肾功能衰竭患者不同治疗方式的血清瘦素

获取原文
           

摘要

Aim: To study serum leptin level in chronic renal failure (CRF) patients on different modes of management and to analyze the impact of the mode of therapy on serum leptin level. Subjects and Methods: This study was conducted on 64 patients (33males&31females) with chronic renal failure divided into three groups: group I: Twenty-six patients treated conservatively and did not start dialysis yet (predialysis), group II: Twenty-four patients treated by hemodialysis, group III: Fourteen patients treated by continuous ambulatory peritoneal dialysis (CAPD). Twenty healthy subjects were included as control group. All patients and controls were subjected to full clinical examination including height and weight to calculate body mass index (BMI). Blood urea and serum creatinine were measured as renal function tests. Serum leptin was measured by EASIA and so serum insulin. Results: In predialysis and CAPD groups, there is a significant increase in leptin , leptin/ BMI and insulin in patients in comparison to control subjects. In hemodialysis group, there is a significant increase in leptin and leptin/ BMI and a non-significant increase in insulin level in patients in comparison to control subjects. Insulin is significantly correlated with leptin in the first group, while in the second and third groups there is no correlation. The highest leptin level is found in the CAPD group of patients followed by the predialysis one then the hemodialysis group. Leptin level is significantly higher in females than males in all groups. This difference remained after adjusting leptin level to BMI. No correlation was found between leptin level and age or between leptin level and renal function in the three groups of patients. No correlation was found between leptin level and the duration of dialysis in the hemodialysis and CAPD groups. Conclusion: Serum leptin is elevated in CRF patients irrespective of the type of management they are undergoing. Dialysis, has no significant effect on leptin level. The two main predictors of serum leptin level are sex and BMI in CRF patients and in healthy subjects. Leptin level may serve as a valuable clinical marker for body adiposity
机译:目的:研究慢性肾衰竭(CRF)患者在不同治疗方式下的血清瘦素水平,并分析治疗方式对血清瘦素水平的影响。研究对象和方法:本研究针对64例慢性肾功能衰竭患者(33例男性和31例女性)分为三组:第一组:二十六个保守治疗且尚未开始透析(透析前)的患者,第二组:二十四治疗的患者通过血液透析,第三组:14例接受连续非卧床腹膜透析(CAPD)治疗。二十名健康受试者作为对照组。所有患者和对照组均接受包括身高和体重在内的全面临床检查,以计算体重指数(BMI)。测量血尿素和血清肌酐作为肾功能测试。通过EASIA测量血清瘦素,然后通过血清胰岛素测量。结果:在透析前和CAPD组中,与对照组相比,患者的瘦素,瘦素/ BMI和胰岛素显着增加。在血液透析组中,与对照组相比,患者的瘦素和瘦素/ BMI显着增加,胰岛素水平无显着增加。在第一组中,胰岛素与瘦素显着相关,而在第二和第三组中,则没有相关性。瘦素水平最高的是CAPD组患者,其次是透析前,然后是血液透析组。在所有组中,女性的瘦素水平均明显高于男性。将瘦素水平调整为BMI后,这种差异仍然存在。在三组患者中,瘦素水平与年龄或瘦素水平与肾功能之间没有相关性。在血液透析组和CAPD组中,瘦素水平与透析时间之间没有相关性。结论:CRF患者的血清瘦素水平升高,而与他们所进行的治疗类型无关。透析对瘦素水平无明显影响。血清瘦素水平的两个主要预测指标是CRF患者和健康受试者的性别和BMI。瘦素水平可能是人体肥胖的重要临床指标

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号